Key Themes & Topics
ADC Supply Chain Integration
Solving the "fragmentation fracture" by de-risking the logistics of high-potency payloads (HPAPI) and linkers sourced from Asia for European conjugation.
Next-Gen Conjugation & Bispecifics
Accessing Asian innovation in Bispecific ADCs (bsADCs) and novel linker chemistries, moving from outsourcing to co-development and licensing.
Analytical Harmonisation
Standardising analytical assays (DAR, free payload) to ensure seamless technology transfer and product comparability between EU labs and Asian sites.
Manufacturing Scalability & HPAPI Safety
Best practices for high-potency containment, single-pot synthesis, and scaling up purification for commercial ADC launches.
WHO
For Heads of CMC, ADC Development, and Supply Chain Leaders focused on the complex development and manufacturing of antibody-drug conjugates.
WHAT
The technical summit for ADC supply chain integration, connecting linker/payload chemists with antibody manufacturers and fill-finish specialists.
WHY
To overcome the supply chain fragmentation that plagues ADCs, ensuring you have the capacity and technical capability to meet the 2030 market demand.
Senior Attendees
Meet a concentrated audience of Heads of CMC, ADC Development, and Supply Chain Leaders focused on the end-to-end production of antibody-drug conjugates.
Expert Speakers
Hear from world-class leaders in conjugation chemistry, HPAPI containment, analytical characterisation, and supply chain integration for complex biologics.
Companies Represented
A technical gathering representing global ADC innovators, specialist linker-payload suppliers, conjugation CDMOs, and fill-finish experts.
Networking Hours
Connect with technical leaders to solve supply chain fragmentation, harmonise analytical standards, and accelerate the commercialisation of next-gen ADCs.
